NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc.(OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that it received a visit today by the Israeli Minister of Industry, Trade and Labor, Mr. Binyamin Ben-Eliezer and the Israeli Chief Scientist, Dr. Eli Opper. The purpose of the visit was to review BrainStorm’s progress towards the start of its first clinical trials in ALS. Minister Ben-Eliezer and Dr. Opper met with BrainStorm’s management and scientific team during their visit and received a detailed presentation of the Company’s science from Professor Eldad Melamed, BrainStorm’s Chief Medical Advisor and Professor Daniel Offen, BrainStorm’s Chief Scientific advisor.
